Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Direxion S&P Biotech Bear 3X (NY: LABD)
11.85 USD  +0.31 (+2.69%)
Official Closing Price  /  Updated: 8:00 PM EST, Jan 17, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Direxion S&P Biotech Bear 3X
Sector
Exchange Traded NY
Net Assets 1.53M
Inception Date
Related Funds
Quote
Price 11.85
Volume 3,765,300
Last Trade Jan 17, 8:00pm
Change (%)
+0.31 (2.69%)
Prev. Close 11.54
YTD %
-5.80%
Dividend Yield 1.30%
Performance
YTD
-0.73 (-5.80%)
1 Month
-0.29 (-2.39%)
3 Month
-10.99 (-48.12%)
6 Month
-7.49 (-38.73%)
1 Year
-14.86 (-55.63%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Interesting LABD Put And Call Options For February 28th
Investors in Direxion Shares Exchange Traded Fund Trust - Daily S&P Biotech Bear 3X 2018 (LABD) saw new options begin trading today, for the February 28th expiration. At Stock Options Channel, our... Read More
from Market News Video
Interesting LABD Put And Call Options For February 2020
Investors in Direxion Shares Exchange Traded Fund Trust - Daily S&P Biotech Bear 3X 2018 (LABD) saw new options become available today, for the February 2020 expiration. At Stock Options Channel, our... Read More
from Market News Video
Top News
More News
Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend
The biotech and healthcare space has been on fire lately. The healthcare space is witnessing a Mergers and Acquisitions wave recently that has achieved an impressive $342 billion in new deal activity... Read More
from ETF Trends
Interesting LABD Put And Call Options For January 2020
Investors in Direxion Shares Exchange Traded Fund Trust - Daily S&P Biotech Bear 3X 2018 (LABD) saw new options begin trading today, for the January 2020 expiration. At Stock Options Channel, our... Read More
from Market News Video
6 Best Leveraged Inverse ETFs Of Past Week
Here aresix leveraged inverse ETFs that are up more than 15% over the past week though these involve a great deal of risk when compared to traditional products. This trend might continue at least for... Read More
from Blogs - TalkMarkets
These Are The Leveraged ETFs At Play When Trade War Worries Strike
The U.S.-China trade war is more than 18 months old. And in that time the conflict has taken a toll on stocks across the world and put ... Read More
from Benzinga
A Beloved Biotech ETF Could Lure Traders Again
With biotechnology stocks and the related exchange-traded funds recently showing some signs of life, it could be just a matter of time ... Read More
from Benzinga
A Big Week for Betting On the CURE for Cancer
One of the biggest healthcare conferences of the year just ended—the American Society of Clinical Oncology Annual Meeting. Since ASCO was founded in 1964, funding for cancer research has gone from less... Read More
from ETF Trends
A Big Week for Betting On the CURE for Cancer
By Direxion One of the biggest healthcare conferences of the year just ended—the American Society of Clinical Oncology Annual Meeting. Since ASCO was founded in 1964, funding for cancer research has... Read More
from ETFdb
5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far In Q2
Although these products involve a great deal of risk when compared with traditional products, ETF investors seeking to tap abrupt movements can go long or short in the near term. Read More
from Blogs - TalkMarkets
5 Leveraged ETFs For Q2 Of 2019
With market volatility on the rise due to heightened tensions from the U.S. trade beef with China, Brexit negotiations, and general global uncertainty and political unrest, savvy investors are looking... Read More
from ETFdb
5 Leveraged ETFs For Q2 Of 2019
With market volatility on the rise due to heightened tensions from the U.S. trade beef with China, Brexit negotiations, and general global uncertainty and political unrest, savvy investors are looking... Read More
from ETF Trends
Interesting LABD Put And Call Options For July 19th
Investors in Direxion Shares Exchange Traded Fund Trust - Daily S&P Biotech Bear 3X 2018 (LABD) saw new options begin trading this week, for the July 19th expiration. At Stock Options Channel, our... Read More
from Market News Video
Big Moves In Leveraged Biotech ETFs
Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price ... Read More
from Benzinga
BNDX, LABD: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Vanguard Total International Bond ETF (BNDX), which added 45,344,195... Read More
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.